Aegerion Pharmaceuticals, Inc.
(NASDAQ : AEGR)

( )
AEGR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
0.20%56.591.4%$1311.45m
JNJJohnson & Johnson
0.85%135.970.7%$915.19m
MRKMerck & Co., Inc.
0.74%85.280.7%$785.59m
PFEPfizer Inc.
-1.73%37.010.9%$756.57m
ABBVAbbVie, Inc.
-2.06%87.192.3%$690.74m
LLYEli Lilly & Co.
-0.42%114.621.1%$412.81m
NVSNovartis AG
0.13%90.520.2%$154.90m
AZNAstraZeneca Plc
-1.41%47.001.2%$146.97m
RETAReata Pharmaceuticals, Inc.
3.35%212.893.5%$140.69m
GSKGlaxoSmithKline Plc
-1.33%43.910.2%$125.31m
KRTXKaruna Therapeutics, Inc.
-12.13%108.950.0%$117.04m
NVONovo Nordisk A/S
-4.54%54.450.1%$83.06m
SNYSanofi
-0.58%45.950.2%$63.37m
RARXRa Pharmaceuticals, Inc.
0.17%46.710.8%$36.92m
CNSTConstellation Pharmaceuticals, Inc.
2.35%40.950.0%$34.35m

Company Profile

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis in 2005 and is headquartered in Cambridge, MA.